久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

India to assess side effects of COVID-19 vaccine

expresspharmaApril 12, 2021

Tag: India , COVID-19 Vaccine , side effect , blood clot

A panel of Indian experts is investigating if there are any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in the country, reported Mint, a financial newspaper.

India is currently administering AstraZeneca’s COVID-19 vaccine and a shot developed at home by Bharat Biotech.

Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination.

Previous:Remdesivir’s price must not be more than Rs 1400 per vial: Maha Health Minister

Next:Biogen and Bio-Thera enter licencing agreement for arthritis biosimilar

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service